Clinical Trial Highlights - GLP-1 agonists
Seek medical attention if you experience severe vomiting preventing fluid intake, signs of dehydration, bloody diarrhoea with fever, or severe persistent abdominal pain
Best for: immune function adjunct, post-illness recovery and fatigue, chronic inflammation Duration: 6090 minutes (dose-dependent) Doses: 10g, 25g, 50g+ Note: patients with G6PD cannot receive this therapy
After 56 weeks of treatment in EQUIP, body weight reduction from baseline was 10.9%, and 5.1%, with high (15/92 mg), and low (3.75/23 mg), doses of PHEN/TPM, respectively (vs
Ozempic (Semaglutide GLP-1) injections promote medical weight loss through several mechanisms that go beyond curbing hunger